OPT · ASX

Opthea Limited (ASX:OPT)

AU$0.6

 0.0 (0.0%)
ASX:Live
18/03/2025 12:00:00 AM
Short Sold >1 over the month Recent Earnings downgrade Near Support HALO Small HALO Ords +7
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

OPT Overview

OPT Health Scores

Short Term

Mean Reversion

Very Weak

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Very Strong

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Strong

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About OPT

Website

Opthea Limited

Telephone

61.3.9826.0399

Address

Level 4 Suite 0403 650 Chapel Street South Yarra, Victoria (VIC) 3141

Description

Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984, and is headquartered in South Yarra, Australia.

OPT Price Chart

Key Stats

Market Cap

AU$738.77M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.34 - 1.16

Trade Value (12mth)

US$377,033.00

1 week

-0.83%

1 month

-37.5%

YTD

-21.57%

1 year

5.07%

All time high

3.60

Key Fundamentals

EPS 3 yr Growth

180.90%

EBITDA Margin

%

Operating Cashflow

-$161m

Free Cash Flow Return

-275.90%

ROIC

-377.40%

Interest Coverage

-6.30

Quick Ratio

2.90

Other Data

Shares on Issue (Fully Dilluted)

1219m

HALO Sector

Healthcare

Next Company Report Date

28-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

USD

Short Sell (% of issue)

3.90

OPT Announcements

Latest Announcements

Date Announcements

19 March 25

Voluntary suspension

×

Voluntary suspension

17 March 25

Trading Halt

×

Trading Halt

14 March 25

Update - Application for quotation of securities - OPT

×

Update - Application for quotation of securities - OPT

14 March 25

Application for quotation of securities - OPT

×

Application for quotation of securities - OPT

14 March 25

Application for quotation of securities - OPT

×

Application for quotation of securities - OPT

14 March 25

Becoming a substantial holder

×

Becoming a substantial holder

11 March 25

Application for quotation of securities - OPT

×

Application for quotation of securities - OPT

11 March 25

Application for quotation of securities - OPT

×

Application for quotation of securities - OPT

03 March 25

Opthea Announces Phase 2b Wet AMD Publication

×

Opthea Announces Phase 2b Wet AMD Publication

28 February 25

Opthea Half Year Financial Report - Appendix 4D

×

Opthea Half Year Financial Report - Appendix 4D

28 February 25

Opthea Reports Half Year Results and Business Updates

×

Opthea Reports Half Year Results and Business Updates

26 February 25

Opthea Completes Drug Product PPQ Campaign

×

Opthea Completes Drug Product PPQ Campaign

21 February 25

Application for quotation of securities - OPT

×

Application for quotation of securities - OPT

21 February 25

Application for quotation of securities - OPT

×

Application for quotation of securities - OPT

19 February 25

Application for quotation of securities - OPT

×

Application for quotation of securities - OPT

18 February 25

Opthea Completes COAST Final Week 52 Patient Visit

×

Opthea Completes COAST Final Week 52 Patient Visit

17 February 25

Application for quotation of securities - OPT

×

Application for quotation of securities - OPT

11 February 25

Application for quotation of securities - OPT

×

Application for quotation of securities - OPT

11 February 25

Notification of cessation of securities - OPT

×

Notification of cessation of securities - OPT

07 February 25

Opthea to Present at Oppenheimer Healthcare Conference

×

Opthea to Present at Oppenheimer Healthcare Conference

06 February 25

Opthea Wet AMD Data Featured at Macula Society Meeting

×

Opthea Wet AMD Data Featured at Macula Society Meeting

04 February 25

Change in substantial holding

×

Change in substantial holding

31 January 25

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

30 January 25

Application for quotation of securities - OPT

×

Application for quotation of securities - OPT

29 January 25

Opthea Investor Day

×

Opthea Investor Day

OPT Fundamentals

Per Share Records

Historical data

Forecast data

USD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.23 -0.28 -0.35 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.23 -0.28 -0.35 Lock Lock Lock
     Growth % Lock Lock Lock Lock -86.6 -22.0 -23.4 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.21 -0.25 -0.16 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.18 -0.24 -0.25 Lock Lock Lock
     Growth % Lock Lock Lock Lock -191.2 -17.9 34.7 Lock Lock Lock
     Yield % Lock Lock Lock Lock -25.4 -73.7 -110.0 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.12 -0.01 -0.07 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.12 -0.01 -0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock -64.7 -109.2 -538.5 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 405 510 638 Lock Lock Lock
Basic m Lock Lock Lock Lock 405 510 638 Lock Lock Lock

Financial Records

Historical data

Forecast data

USD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 32.2 19.5 15.0 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 97 150 192 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.0 0.0 17.4 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 0 0 83 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -97 -150 -192 Lock Lock Lock
     Growth % Lock Lock Lock Lock -144.1 -55.5 -27.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -106,489.5 -138,554.5 -153,912.8 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -97 -150 -192 Lock Lock Lock
     Growth % Lock Lock Lock Lock -143.6 -55.5 -27.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -106,576.0 -138,647.9 -153,995.4 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -99 -148 -230 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -6 -6 -9 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -93 -143 -220 Lock Lock Lock
     Growth % Lock Lock Lock Lock -104.7 -53.6 -54.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -102,353.7 -131,469.7 -176,665.7 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -71 -121 -161 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 167 244 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -71 -121 -161 Lock Lock Lock
     Growth % Lock Lock Lock Lock -56.6 -69.1 -33.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -786.8 -1,112.8 -1,291.8 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 45 89 172 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 60 99 189 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 201 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -45 -89 28 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 12 104 265 Lock Lock Lock
Equity $m Lock Lock Lock Lock 51 -6 -74 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 48 -6 125 Lock Lock Lock
     Growth % Lock Lock Lock Lock -64.5 -112.0 2,262.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -154.6 -144.5 -116.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -183.4 2,409.6 296.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -106.6 -729.6 -328.5 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -102.4 -693.5 -377.4 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -78.7 -586.9 -275.9 Lock Lock Lock

Ratios Records

Historical data

Forecast data

USD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock N/A -11.2 -6.3 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.5 0.6 -0.1 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -88.2 1,504.8 -37.9 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 5.0 5.2 2.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 5.0 5.2 2.9 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 74.5 90.7 91.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -592.4 -643.5 -251.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 13,260.1 16,632.4 29,955.2 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -109,300.2 -136,936.5 -184,215.7 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -165.1 -150.5 -121.6 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -154.6 -144.5 -116.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 -16.7 -2.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -183.4 2,409.6 296.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -183.4 2,409.6 296.1 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 24,682.5 21,962.4 26,442.3 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 24,682.5 21,962.4 26,442.3 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 0.0 0.0 96,052.6 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 24,682.5 21,962.4 -69,610.3 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

3.90%

Value ($M)

30

Prior Change

0.60%

7 Day Change

0.60%

1 Month Change

2.70%

3 Month Change

2.80%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

OPT Shortsell

Frequently Asked Questions

The current share price of Opthea Limited (OPT:ASX) is AU$0.6.
The 52-week high share price for Opthea Limited (OPT:ASX) is AU$1.16.
The 52-week low share price for Opthea Limited (OPT:ASX)? is AU$0.34.
Opthea Limited (OPT:ASX) does not pay a dividend.
The last dividend payment of Opthea Limited (OPT:ASX) is AU$0.15.
Opthea Limited (OPT:ASX) has a franking level of 0.0%.
Opthea Limited (OPT:ASX) is classified in the Healthcare.
The current P/E ratio for Opthea Limited (OPT:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.